Navigation Links
GenuTrain P3

ProductsGenuTrain P3
Company Bauerfeind USA, Inc.
Item GenuTrain P3
Features 
  • Anatomically knitted support incorporating contoured silicone insert surrounding the patella
  • An integrated guide keeps the patella from shifting out of place
  • During activity the insert not only counteracts patellar malalignment but provides intermittent compression for the reduction of swelling and edema
  • Promotes proprioception, thus heightening sensory awareness in the knee for increased joint stabilization
  • Innovative trapezoidal stitch in the popliteal region prevents bunching and pinching
  • Anatomical knit with graduated compression graduated toward the edges prevents constiction of circulation and rolling of the support
  • Silicone banding at top of support and medial/lateral stays guard against migration
  • Lightweight, breathable knit will not retain heat and is completely machine washable
    • Description GenuTrain P3 is a support that centers the patella during joint movement.
    Info Bauerfeind USA, Inc.
    Customer Service: 800.423.3405
    Web site: http://www.bauerfeindusa.com/

    Related medicine products :

    1. GenuTrain
    TAG: GenuTrain
    Other Medicine News:Health News:Video: Grin Big With an Award-Winning Smile 2Health News:Video: Grin Big With an Award-Winning Smile 3Health News:Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years 2Health News:Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years 3Health News:Pharmos Restructures Operations in Israel 2Health News:Pharmos Restructures Operations in Israel 3Health News:Ranbaxy Receives Tentative Approval For Valsartan Tablets 2Health News:TenderCare International, Inc. Announces Signing of Merger Agreement with the Hain Celestial Group for All Outstanding Shares of TenderCare Stock 2Health News:Merge Healthcare Provides Update on the Restatement of Its Financial Statements 2Health News:Merge Healthcare Provides Update on the Restatement of Its Financial Statements 3Health News:Merge Healthcare Provides Update on the Restatement of Its Financial Statements 4Health News:Merge Healthcare Provides Update on the Restatement of Its Financial Statements 5
    Breaking Medicine Technology:Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 2Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 3Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 4New Executive Leadership and CEO Announced for BiPar Sciences 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4Women 26apos 3Bs Pelvic Organ Prolapse and Incontinence Guide Informs Outlines Treatments 57906 1Women 26apos 3Bs Pelvic Organ Prolapse and Incontinence Guide Informs Outlines Treatments 57906 2Women 26apos 3Bs Pelvic Organ Prolapse and Incontinence Guide Informs Outlines Treatments 57906 3Link High Technologies to Offer Allscripts MyWay Affordable Electronic Health Records to NJ Physicians 57903 1Link High Technologies to Offer Allscripts MyWay Affordable Electronic Health Records to NJ Physicians 57903 2Link High Technologies to Offer Allscripts MyWay Affordable Electronic Health Records to NJ Physicians 57903 3Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 1Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 2Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 3Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 4Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 5Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 6Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 7Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 8